96 related articles for article (PubMed ID: 10382996)
21. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
Wolf WC; Yoshida H; Agata J; Chao L; Chao J
Kidney Int; 2000 Aug; 58(2):730-9. PubMed ID: 10916096
[TBL] [Abstract][Full Text] [Related]
22. Increased atrial natriuretic peptide mRNA expression in the kidney of diabetic rats.
Shin SJ; Lee YJ; Tan MS; Hsieh TJ; Tsai JH
Kidney Int; 1997 Apr; 51(4):1100-5. PubMed ID: 9083275
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
Ma J; Peng A; Lin S
Chin Med J (Engl); 1998 Jan; 111(1):17-23. PubMed ID: 10322646
[TBL] [Abstract][Full Text] [Related]
24. Restoration of renal responsiveness to atrial natriuretic peptide in experimental nephrotic syndrome by albumin infusion.
Abassi Z; Weissman I; Karram T; Goltsman I; Hoffman A; Better OS; Winaver J
Am J Nephrol; 2013; 38(4):292-9. PubMed ID: 24080549
[TBL] [Abstract][Full Text] [Related]
25. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
[TBL] [Abstract][Full Text] [Related]
26. Atrial natriuretic peptide protects against cisplatin-induced acute kidney injury.
Nojiri T; Hosoda H; Kimura T; Miura K; Ishikane S; Tokudome T; Shintani Y; Inoue M; Miyazato M; Okumura M; Kangawa K
Cancer Chemother Pharmacol; 2015 Jan; 75(1):123-9. PubMed ID: 25385303
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
Sano T; Morishita Y; Matsuda Y; Yamada K
J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647
[TBL] [Abstract][Full Text] [Related]
28. Captopril and ANP: changes in renal hemodynamics, glomerular-ANP receptors and guanylate cyclase activity in rats with heart failure.
Lee RW; Raya TE; Michael U; Foster S; Meeks T; Goldman S
J Pharmacol Exp Ther; 1992 Jan; 260(1):349-54. PubMed ID: 1346164
[TBL] [Abstract][Full Text] [Related]
29. The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats.
Ruskoaho H; Leppäluoto J
Br J Pharmacol; 1989 May; 97(1):125-32. PubMed ID: 2566350
[TBL] [Abstract][Full Text] [Related]
30. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats.
Dobrzynski E; Wang C; Chao J; Chao L
Hypertension; 2000 Dec; 36(6):995-1001. PubMed ID: 11116114
[TBL] [Abstract][Full Text] [Related]
31. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
Scavone C; Scanlon C; McKee M; Nathanson JA
J Pharmacol Exp Ther; 1995 Mar; 272(3):1036-43. PubMed ID: 7891313
[TBL] [Abstract][Full Text] [Related]
32. Chronic administration of phosphodiesterase type 5 inhibitor suppresses renal production of endothelin-1 in dogs with congestive heart failure.
Yamamoto T; Wada A; Ohnishi M; Tsutamoto T; Fujii M; Matsumoto T; Takayama T; Wang X; Kurokawa K; Kinoshita M
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():258S-262S. PubMed ID: 12193099
[TBL] [Abstract][Full Text] [Related]
33. The beneficial effect of atrial natriuretic peptide on cyclosporine nephrotoxicity.
Capasso G; Rosati C; Ciani F; Giordano DR; Russo F; De Santo NG
Am J Hypertens; 1990 Mar; 3(3):204-10. PubMed ID: 2138899
[TBL] [Abstract][Full Text] [Related]
34. Neurohumoral mechanism in the natriuretic action of intracerebroventricular administration of renin.
Zavala L; Barbella Y; Israel A
J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):39-44. PubMed ID: 15136973
[TBL] [Abstract][Full Text] [Related]
35. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats.
Tremblay J; Huot C; Willenbrock RC; Bayard F; Gossard F; Fujio N; Koch C; Kuchel O; Debinski W; Hamet P
J Clin Invest; 1993 Nov; 92(5):2499-508. PubMed ID: 7901238
[TBL] [Abstract][Full Text] [Related]
36. Renal function after myocardial infarction and cardiac arrest in rats: role of ANP-induced albuminuria?
Nielsen SH; Magid E; Spannow J; Christensen S; Lam HR; Petersen JS
Acta Physiol Scand; 1997 Aug; 160(4):301-10. PubMed ID: 9338510
[TBL] [Abstract][Full Text] [Related]
37. Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat.
Ballermann BJ; Bloch KD; Seidman JG; Brenner BM
J Clin Invest; 1986 Sep; 78(3):840-3. PubMed ID: 3018046
[TBL] [Abstract][Full Text] [Related]
38. Atrial natriuretic peptide attenuates kidney-lung crosstalk in kidney injury.
Tulafu M; Mitaka C; Hnin Si MK; Abe S; Kitagawa M; Ikeda S; Eishi Y; Kurata S; Tomita M
J Surg Res; 2014 Jan; 186(1):217-25. PubMed ID: 23953791
[TBL] [Abstract][Full Text] [Related]
39. Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.
Pang A; Hu Y; Zhou P; Long G; Tian X; Men L; Shen Y; Liu Y; Cui Y
Cardiovasc Diabetol; 2015 Oct; 14():134. PubMed ID: 26446774
[TBL] [Abstract][Full Text] [Related]
40. Kinetics and pharmacodynamics of atrial natriuretic peptide and lithium clearance in the isolated perfused rat kidney.
Brier ME; Brier RA; Luft FC; Aronoff GR
J Pharmacol Exp Ther; 1987 Dec; 243(3):868-73. PubMed ID: 2961879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
